ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genetic Modification Therapies Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-9H13582
Home | Market Reports | Science| Biological Sciences
Global Genetic Modification Therapies Market Research Report 2023
BUY CHAPTERS

Global Genetic Modification Therapies Market Insights, Forecast to 2030

Code: QYRE-Auto-9H13582
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
4D Molecular Therapeutics
Abeona Therapeutics
Allergan plc
American Gene Technologies
Merck Millipore
AbbVie

Genetic Modification Therapies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Genetic Modification Therapies Market

Genetic Modification Therapies Market

Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.
Market Analysis and Insights: Global Genetic Modification Therapies Market
The global Genetic Modification Therapies market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Genetic Modification Therapies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Genetic Modification Therapies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genetic Modification Therapies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genetic Modification Therapies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Genetic Modification Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Genetic Modification Therapies revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Genetic Modification Therapies Market Report

Report Metric Details
Report Name Genetic Modification Therapies Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 4D Molecular Therapeutics, Abeona Therapeutics, Allergan, American Gene Technologies, Merck Millipore, AbbVie
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Genetic Modification Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Genetic Modification Therapies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Modification Therapies revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Genetic Modification Therapies Market report?

Ans: The main players in the Genetic Modification Therapies Market are 4D Molecular Therapeutics, Abeona Therapeutics, Allergan, American Gene Technologies, Merck Millipore, AbbVie

What are the Application segmentation covered in the Genetic Modification Therapies Market report?

Ans: The Applications covered in the Genetic Modification Therapies Market report are Hospitals, Diagnostics and Testing Laboratories, Academic and Research Organizations, Others

What are the Type segmentation covered in the Genetic Modification Therapies Market report?

Ans: The Types covered in the Genetic Modification Therapies Market report are Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, Gene Editing

Recommended Reports

Gene & Cell Therapy

Cancer Therapeutics

Drug Delivery & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Modification Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Gene Therapies
1.2.3 Genetically Modified Cell Therapies
1.2.4 RNA Therapies
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Genetic Modification Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Modification Therapies Market Perspective (2019-2030)
2.2 Global Genetic Modification Therapies Growth Trends by Region
2.2.1 Genetic Modification Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Modification Therapies Historic Market Size by Region (2019-2024)
2.2.3 Genetic Modification Therapies Forecasted Market Size by Region (2025-2030)
2.3 Genetic Modification Therapies Market Dynamics
2.3.1 Genetic Modification Therapies Industry Trends
2.3.2 Genetic Modification Therapies Market Drivers
2.3.3 Genetic Modification Therapies Market Challenges
2.3.4 Genetic Modification Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Genetic Modification Therapies by Players
3.1.1 Global Genetic Modification Therapies Revenue by Players (2019-2024)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Genetic Modification Therapies, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Genetic Modification Therapies Market Concentration Ratio
3.4.1 Global Genetic Modification Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Modification Therapies Revenue in 2023
3.5 Global Key Players of Genetic Modification Therapies Head office and Area Served
3.6 Global Key Players of Genetic Modification Therapies, Product and Application
3.7 Global Key Players of Genetic Modification Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Modification Therapies Breakdown Data by Type
4.1 Global Genetic Modification Therapies Historic Market Size by Type (2019-2024)
4.2 Global Genetic Modification Therapies Forecasted Market Size by Type (2025-2030)
5 Genetic Modification Therapies Breakdown Data by Application
5.1 Global Genetic Modification Therapies Historic Market Size by Application (2019-2024)
5.2 Global Genetic Modification Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genetic Modification Therapies Market Size (2019-2030)
6.2 North America Genetic Modification Therapies Market Size by Type
6.2.1 North America Genetic Modification Therapies Market Size by Type (2019-2024)
6.2.2 North America Genetic Modification Therapies Market Size by Type (2025-2030)
6.2.3 North America Genetic Modification Therapies Market Share by Type (2019-2030)
6.3 North America Genetic Modification Therapies Market Size by Application
6.3.1 North America Genetic Modification Therapies Market Size by Application (2019-2024)
6.3.2 North America Genetic Modification Therapies Market Size by Application (2025-2030)
6.3.3 North America Genetic Modification Therapies Market Share by Application (2019-2030)
6.4 North America Genetic Modification Therapies Market Size by Country
6.4.1 North America Genetic Modification Therapies Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Genetic Modification Therapies Market Size by Country (2019-2024)
6.4.3 North America Genetic Modification Therapies Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genetic Modification Therapies Market Size (2019-2030)
7.2 Europe Genetic Modification Therapies Market Size by Type
7.2.1 Europe Genetic Modification Therapies Market Size by Type (2019-2024)
7.2.2 Europe Genetic Modification Therapies Market Size by Type (2025-2030)
7.2.3 Europe Genetic Modification Therapies Market Share by Type (2019-2030)
7.3 Europe Genetic Modification Therapies Market Size by Application
7.3.1 Europe Genetic Modification Therapies Market Size by Application (2019-2024)
7.3.2 Europe Genetic Modification Therapies Market Size by Application (2025-2030)
7.3.3 Europe Genetic Modification Therapies Market Share by Application (2019-2030)
7.4 Europe Genetic Modification Therapies Market Size by Country
7.4.1 Europe Genetic Modification Therapies Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Genetic Modification Therapies Market Size by Country (2019-2024)
7.4.3 Europe Genetic Modification Therapies Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Genetic Modification Therapies Market Size (2019-2030)
8.2 China Genetic Modification Therapies Market Size by Type
8.2.1 China Genetic Modification Therapies Market Size by Type (2019-2024)
8.2.2 China Genetic Modification Therapies Market Size by Type (2025-2030)
8.2.3 China Genetic Modification Therapies Market Share by Type (2019-2030)
8.3 China Genetic Modification Therapies Market Size by Application
8.3.1 China Genetic Modification Therapies Market Size by Application (2019-2024)
8.3.2 China Genetic Modification Therapies Market Size by Application (2025-2030)
8.3.3 China Genetic Modification Therapies Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Genetic Modification Therapies Market Size (2019-2030)
9.2 Asia Genetic Modification Therapies Market Size by Type
9.2.1 Asia Genetic Modification Therapies Market Size by Type (2019-2024)
9.2.2 Asia Genetic Modification Therapies Market Size by Type (2025-2030)
9.2.3 Asia Genetic Modification Therapies Market Share by Type (2019-2030)
9.3 Asia Genetic Modification Therapies Market Size by Application
9.3.1 Asia Genetic Modification Therapies Market Size by Application (2019-2024)
9.3.2 Asia Genetic Modification Therapies Market Size by Application (2025-2030)
9.3.3 Asia Genetic Modification Therapies Market Share by Application (2019-2030)
9.4 Asia Genetic Modification Therapies Market Size by Region
9.4.1 Asia Genetic Modification Therapies Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Genetic Modification Therapies Market Size by Region (2019-2024)
9.4.3 Asia Genetic Modification Therapies Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Genetic Modification Therapies Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Genetic Modification Therapies Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Details
11.1.2 4D Molecular Therapeutics Business Overview
11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
11.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024)
11.1.5 4D Molecular Therapeutics Recent Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Company Details
11.2.2 Abeona Therapeutics Business Overview
11.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
11.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024)
11.2.5 Abeona Therapeutics Recent Developments
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Genetic Modification Therapies Introduction
11.3.4 Allergan Revenue in Genetic Modification Therapies Business (2019-2024)
11.3.5 Allergan Recent Developments
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Details
11.4.2 American Gene Technologies Business Overview
11.4.3 American Gene Technologies Genetic Modification Therapies Introduction
11.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2019-2024)
11.4.5 American Gene Technologies Recent Developments
11.5 Merck Millipore
11.5.1 Merck Millipore Company Details
11.5.2 Merck Millipore Business Overview
11.5.3 Merck Millipore Genetic Modification Therapies Introduction
11.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2019-2024)
11.5.5 Merck Millipore Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Genetic Modification Therapies Introduction
11.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2019-2024)
11.6.5 AbbVie Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
4D Molecular Therapeutics
Abeona Therapeutics
Allergan plc
American Gene Technologies
Merck Millipore
AbbVie
List of Tables
    Table 1. Global Genetic Modification Therapies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Gene Therapies
    Table 3. Key Players of Genetically Modified Cell Therapies
    Table 4. Key Players of RNA Therapies
    Table 5. Key Players of Gene Editing
    Table 6. Global Genetic Modification Therapies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Genetic Modification Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Genetic Modification Therapies Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Genetic Modification Therapies Market Share by Region (2019-2024)
    Table 10. Global Genetic Modification Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Genetic Modification Therapies Market Share by Region (2025-2030)
    Table 12. Genetic Modification Therapies Market Trends
    Table 13. Genetic Modification Therapies Market Drivers
    Table 14. Genetic Modification Therapies Market Challenges
    Table 15. Genetic Modification Therapies Market Restraints
    Table 16. Global Genetic Modification Therapies Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Genetic Modification Therapies Revenue Share by Players (2019-2024)
    Table 18. Global Top Genetic Modification Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2023)
    Table 19. Global Genetic Modification Therapies Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Genetic Modification Therapies Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Genetic Modification Therapies, Headquarters and Area Served
    Table 22. Global Key Players of Genetic Modification Therapies, Product and Application
    Table 23. Global Key Players of Genetic Modification Therapies, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Genetic Modification Therapies Revenue Market Share by Type (2019-2024)
    Table 27. Global Genetic Modification Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Genetic Modification Therapies Revenue Market Share by Type (2025-2030)
    Table 29. Global Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Genetic Modification Therapies Revenue Share by Application (2019-2024)
    Table 31. Global Genetic Modification Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Genetic Modification Therapies Revenue Share by Application (2025-2030)
    Table 33. North America Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Genetic Modification Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Genetic Modification Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Genetic Modification Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Genetic Modification Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Genetic Modification Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Genetic Modification Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Genetic Modification Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Genetic Modification Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Genetic Modification Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Genetic Modification Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Genetic Modification Therapies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Genetic Modification Therapies Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Genetic Modification Therapies Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Genetic Modification Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 65. 4D Molecular Therapeutics Company Details
    Table 66. 4D Molecular Therapeutics Business Overview
    Table 67. 4D Molecular Therapeutics Genetic Modification Therapies Product
    Table 68. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 69. 4D Molecular Therapeutics Recent Developments
    Table 70. Abeona Therapeutics Company Details
    Table 71. Abeona Therapeutics Business Overview
    Table 72. Abeona Therapeutics Genetic Modification Therapies Product
    Table 73. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 74. Abeona Therapeutics Recent Developments
    Table 75. Allergan Company Details
    Table 76. Allergan Business Overview
    Table 77. Allergan Genetic Modification Therapies Product
    Table 78. Allergan Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 79. Allergan Recent Developments
    Table 80. American Gene Technologies Company Details
    Table 81. American Gene Technologies Business Overview
    Table 82. American Gene Technologies Genetic Modification Therapies Product
    Table 83. American Gene Technologies Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 84. American Gene Technologies Recent Developments
    Table 85. Merck Millipore Company Details
    Table 86. Merck Millipore Business Overview
    Table 87. Merck Millipore Genetic Modification Therapies Product
    Table 88. Merck Millipore Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 89. Merck Millipore Recent Developments
    Table 90. AbbVie Company Details
    Table 91. AbbVie Business Overview
    Table 92. AbbVie Genetic Modification Therapies Product
    Table 93. AbbVie Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
    Table 94. AbbVie Recent Developments
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genetic Modification Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Genetic Modification Therapies Market Share by Type: 2023 VS 2030
    Figure 3. Gene Therapies Features
    Figure 4. Genetically Modified Cell Therapies Features
    Figure 5. RNA Therapies Features
    Figure 6. Gene Editing Features
    Figure 7. Global Genetic Modification Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Genetic Modification Therapies Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Diagnostics and Testing Laboratories Case Studies
    Figure 11. Academic and Research Organizations Case Studies
    Figure 12. Others Case Studies
    Figure 13. Genetic Modification Therapies Report Years Considered
    Figure 14. Global Genetic Modification Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Genetic Modification Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Genetic Modification Therapies Market Share by Region: 2023 VS 2030
    Figure 17. Global Genetic Modification Therapies Market Share by Players in 2023
    Figure 18. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2023
    Figure 20. North America Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Genetic Modification Therapies Market Share by Type (2019-2030)
    Figure 22. North America Genetic Modification Therapies Market Share by Application (2019-2030)
    Figure 23. North America Genetic Modification Therapies Market Share by Country (2019-2030)
    Figure 24. United States Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Genetic Modification Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Genetic Modification Therapies Market Share by Type (2019-2030)
    Figure 28. Europe Genetic Modification Therapies Market Share by Application (2019-2030)
    Figure 29. Europe Genetic Modification Therapies Market Share by Country (2019-2030)
    Figure 30. Germany Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Genetic Modification Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Genetic Modification Therapies Market Share by Type (2019-2030)
    Figure 38. China Genetic Modification Therapies Market Share by Application (2019-2030)
    Figure 39. Asia Genetic Modification Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Genetic Modification Therapies Market Share by Type (2019-2030)
    Figure 41. Asia Genetic Modification Therapies Market Share by Application (2019-2030)
    Figure 42. Asia Genetic Modification Therapies Market Share by Region (2019-2030)
    Figure 43. Japan Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Genetic Modification Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Genetic Modification Therapies Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Genetic Modification Therapies Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Genetic Modification Therapies Market Share by Country (2019-2030)
    Figure 53. Brazil Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 60. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 61. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 62. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 63. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 64. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Genetic Modification Therapies Clinical Applications Market Research Report 2024
Global Genetic Modification Market Insights Forecast to 2030
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030
Global Human Gene Therapy Market Research Report 2025
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Gene Therapy For Cancer Market Research Report 2024
Global Gene Editing Tools Market Insights Forecast to 2030
Global Gene Therapy in Oncology Market Research Report 2024
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Editing Technologies Market Insights Forecast to 2030
Global Drugs for Treating Metabolic Disorders Market Research Report 2024
Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Global Cell and Gene Therapy Services Market Research Report 2024
Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Editing Therapy Market Research Report 2024
Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Editing Technology Market Research Report 2024
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions